Benign Liver Optimal Core Study (Tissue Acquisition Comparison in Benign Liver Disease)

Inclusion Criteria

• •Subjects that plan to undergo a liver biopsy via EUS to confirm possible underlying liver disease or to determine stage, grade and presence of fibrosis for suspected benign etiology.
• •History of abnormal LFTs
• •Documented history of chronic liver disease
• •Question of underlying liver disease as cause of abnormal imaging or symptoms which may be attributed to liver disorder
• •Fatty liver disease
• •Subjects 18 years of age or older
• •Subject must be able to hold anticoagulants as per institutional standard of care
• •Subjects must be deemed physically able to undergo anesthesia. This includes either Monitored Anesthesia Care (MAC) or general anesthesia.
• •Subjects (or the subjects Legally Authorized Representative \[LAR\]) that have agreed to participate in the study and have signed Informed Consent
• •Women of child bearing potential who are not pregnant as proven by a negative pregnancy test may be included.